Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Pain: Comorbidity of neuropathic pain and migraine in patients with multiple sclerosis.
Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells.
Wnt Signaling in Remyelination in Multiple Sclerosis: Friend or Foe?
Weight status in persons with multiple sclerosis: implications for mobility outcomes.
NONINVASIVE ASSESSMENTS OF OPTIC NERVE NEURODEGENERATION IN TRANSGENIC MICE WITH ISOLATED OPTIC NEURITIS.
Co-existence of tumefactive MS and hepatitis C: A need for further screening and new therapeutic challenge.
[Progressive multifocal leukoencephalopathy associated to natalizumab: the importance of magnetic resonance imaging in its early diagnosis].
[Cormorbidity in multiple sclerosis and its therapeutic approach].
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
Dietary Yeasts Reduce Inflammation in Central Nerve System via Microflora.
Autophagy and neurodegeneration.
Implications for multiple sclerosis in the era of the Affordable Care Act: a clinical overview.
Neuropsychiatric disorders among Syrian and Iraqi refugees in Jordan: a retrospective cohort study 2012-2013.
DGPPN guideline on anxiety disorders and cognitive dysfunction in the elderly or patients with multiple sclerosis.
White Matter MS-Lesion Segmentation Using a Geometric Brain Model.
Longitudinal associations between MRI and cognitive changes in very early MS.
Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.
DRUG DELIVERY TO CNS: CHALLENGES AND OPPORTUNITIES WITH EMPHASIS ON BIOMATERIALS BASED DRUG DELIVERY STRATEGIES.
Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune Encephalomyelitis.
Bone health in patients with multiple sclerosis relapses.
Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary.
Short-Term Effect of High-Dose Vitamin D on the Level of Interleukin 10 in Patients with Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination.
Systematic framework to evaluate the status of physical activity research for persons with multiple sclerosis.
Pages
« first
‹ previous
…
468
469
470
471
472
473
474
475
476
…
next ›
last »